Bioforum will bring the real-world data solutions of Clinerion’s Patient Network Explorer platform to patients and physicians in Israel and Australia, accelerating the development of innovative medications and improving access to new treatments.
Bioforum is a data-focused Contract Research Organization (CRO), offering a wide range of consulting services, including medical writing, data management and bio-statistical support.
Bioforum will support Clinerion by leveraging its network to enlarge Clinerion’s outreach in Bioforum’s target markets of Israel and Australia. Bioforum will also identify potential customers for Clinerion’s services, which enable pharmaceutical trial sponsors to more accurately refine trial protocol criteria and then find and match their trials to sites and patients, accelerating the set-up phase of trials by months.
“We are extremely excited to launch this collaboration and are confident that together we can promote clinical research in our target markets. We are keen to introduce more medical centers to Clinerion’s advanced technology,” says Bioforum’s President & Co-Founder, Mr. Amir Malka.
“Patients in both Israel and Australia are underserved by clinical research at the moment,” says Ian Rentsch, CEO of Clinerion. “We are pleased to have Bioforum on board to support bringing our solutions to market.”
For more information go to www.clinerion.com
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Vabysmo Shows Significant Vision Improvement for Diabetic Macular Edema in Underrepresented Patients
October 22nd 2024Phase IV ELEVATUM trial results show that one year of treatment with Vabysmo significantly improved vision in underrepresented racial and ethnic groups with diabetic macular edema, supporting the drug's efficacy and safety across diverse populations.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Clesrovimab Shows Significant Reduction in RSV Infections, Hospitalizations in Infants
October 18th 2024Merck's investigational monoclonal antibody, clesrovimab, shows significant efficacy in reducing respiratory syncytial virus-related infections and hospitalizations in infants, with a favorable safety profile.